Evidence-based·Last reviewed May 31, 2026·How we grade evidence

Ginsenosides

PhytochemicalBest in the morning

The triterpene saponin bioactives of Panax ginseng (Korean / Asian / Red) and Panax quinquefolius (American). Distinct ginsenosides (Rg1, Rb1, Rg3, Re, etc.) have distinct pharmacology. Real RCT evidence for: cancer-related fatigue (American), erectile dysfunction (Korean red), glycemic control in T2DM (modest), and respiratory infection prevention with the specific CVT-E002 polysaccharide. 'General energy / adaptogen' claims in healthy adults are weakly supported.

Quick decision guide

May help most

Adults with cancer-related fatigue, erectile dysfunction, type 2 diabetes (modest adjunct), or older adults concerned about respiratory infection — under clinician oversight given the real drug interactions.

Common dosing range

Korean red ginseng for ED: 900–2700 mg/day standardized extract. American ginseng for fatigue: 1000–2000 mg/day. American ginseng for diabetes: 1–3 g/day. CVT-E002 for cold prevention: 400 mg/day.

When to expect effects

4–8 weeks for ED, fatigue, glycemic control; 4 months for cold prevention.

Watch out for

Real interactions with warfarin (case reports of decreased INR), hypoglycemic agents (additive hypoglycemia), MAOIs (hypertensive reactions), and CYP3A4 substrates. Insomnia, hypertension, and headache are common dose-limiting side effects.

Evidence snapshot

Erectile dysfunction (Korean red ginseng)Moderate
Cancer-related fatigue (American ginseng)Moderate
Glycemic control in T2DMModerate
Cognitive function in healthy adultsLow
Cold prevention (CVT-E002)Emerging
General 'adaptogen / energy' claimsLow

What is it

Ginsenosides are steroidal saponins responsible for most of ginseng's pharmacology. Major members include Rb1, Rb2, Rc, Rd, Re, Rf, Rg1, and Rg3. Different ginseng species and processing methods yield different ginsenoside profiles.

Is it worth it for you?

Use this as a quick fit check, not a diagnosis.

Worth considering if

You have mild-to-moderate erectile dysfunction and want a non-prescription adjunct or backup to PDE5 inhibitors (Korean red ginseng)
You are receiving cancer treatment with moderate fatigue and your oncologist has not contraindicated ginseng (American ginseng)
You have type 2 diabetes and want a modest adjunct to diet, exercise, and prescribed medications (American ginseng)
You are an older adult prone to recurrent respiratory infections and willing to try the specific CVT-E002 polysaccharide product
You can avoid the major drug interactions (warfarin, MAOIs, hypoglycemics) and you don't have uncontrolled hypertension

Probably skip if

You take warfarin — case reports of reduced INR with ginseng; avoid or only under tight INR monitoring
You take MAOIs (phenelzine, tranylcypromine, selegiline) — risk of hypertensive reaction, manic episodes
You have uncontrolled hypertension, severe insomnia, or anxiety — ginseng can worsen all three
You are pregnant or breastfeeding — insufficient safety data; avoid
You are hoping for evidence-based 'limitless energy' / 'cognitive enhancement' in a healthy adult — Cochrane and major reviews don't support this
You are buying a generic 'ginseng' product without a standardized ginsenoside content — quality varies dramatically between brands
You take any CYP3A4-sensitive medication and can't get drug-interaction screening from a pharmacist

Evidence at a glance

Erectile dysfunction (Korean red ginseng)

Good Evidence
Effect
IIEF score improvement ~5 points over 8–12 weeks at 900–2,700 mg/day red ginseng extract
Best fit
Men with mild-to-moderate ED, especially those wanting non-prescription option or adjunct to sildenafil-class therapy
Time
8–12 weeks

Cancer-related fatigue (American ginseng)

Good Evidence
Effect
Approx 10-point greater fatigue reduction (MFSI-SF) vs placebo at 2000 mg/day American ginseng over 8 weeks
Best fit
Cancer patients with moderate fatigue, on or recently completing chemotherapy, with oncologist clearance
Time
8 weeks

Type 2 diabetes / glycemic control

Good Evidence
Effect
Fasting glucose ~−6 mg/dL pooled; HbA1c reduction inconsistent across trials
Best fit
Adults with T2DM looking for modest adjunct to diet, exercise, and proven medications, under clinician oversight
Time
4–12 weeks

Cognitive function / mental performance

Limited Evidence
Effect
Small acute and subchronic improvements on selected cognitive subscales; clinical relevance uncertain
Best fit
Adults experimenting with low-risk cognitive adjuncts during demanding mental work
Time
Acute (hours) for some attention tasks; weeks for fatigue endpoints

Respiratory infection prevention (CVT-E002 / COLD-fX, American ginseng polysaccharide)

Limited Evidence
Effect
~25–30% reduction in cold incidence and total cold symptom days at 400 mg/day CVT-E002 over 4 months
Best fit
Older adults or institutional residents prone to recurrent colds; willing to use the specific branded product
Time
4 months of consistent use during cold/flu season

General 'energy / adaptogen' use in healthy adults

Weak Evidence
Effect
No reliable clinical-endpoint evidence in healthy adults for the marketed 'energy / immunity / adaptogen' claims
Best fit
None at favorable evidence/risk profile
Time
Not established for general use

Evidence for 6 uses

AI-assisted evidence assessment — talk to your doctor before relying on any single supplement.

Erectile dysfunction (Korean red ginseng)

Supplement benefit
Good Evidence

A 2008 meta-analysis of 7 RCTs (n=349) of Korean red ginseng for erectile dysfunction found significant improvement in International Index of Erectile Function (IIEF) scores vs placebo, with mean improvement around 5 points (clinically meaningful threshold). Doses studied were 9002,700 mg/day standardized red ginseng extract for 812 weeks. Trial quality was variable; effects are modest compared with PDE5 inhibitors but real and reproducible across trials. Ginsenosides Rg1, Rb1, and Rh2 are thought to enhance nitric oxide release in corpus cavernosum smooth muscle.

Effect size
IIEF score improvement ~5 points over 8–12 weeks at 900–2,700 mg/day red ginseng extract
Time to effect
8–12 weeks
Best fit
Men with mild-to-moderate ED, especially those wanting non-prescription option or adjunct to sildenafil-class therapy
Less likely
Men with severe vasculogenic ED or significant prostate/pelvic surgery — PDE5 inhibitors first-line

Bottom line: Real, modest benefit in ED. Smaller effect than sildenafil but useful as adjunct or first try for milder ED.

Cancer-related fatigue (American ginseng)

Disease adjunct
Good Evidence

The Barton 2013 multi-center RCT in 364 cancer patients with fatigue (most on or recently completed chemotherapy) showed 2000 mg/day Wisconsin American ginseng (pure ground root) for 8 weeks significantly reduced fatigue scores (MFSI-SF change20 vs10 placebo, p=0.003) with no significant toxicity. Confirms an earlier 2010 Barton pilot trial. American ginseng (Panax quinquefolius) — not Asian ginsengwas used. The bioactive ginsenoside profile (more Rb1) may matter.

Effect size
Approx 10-point greater fatigue reduction (MFSI-SF) vs placebo at 2000 mg/day American ginseng over 8 weeks
Time to effect
8 weeks
Best fit
Cancer patients with moderate fatigue, on or recently completing chemotherapy, with oncologist clearance
Less likely
People expecting same benefit from Asian / Korean red ginseng (not the trial product) or from low-dose generic extracts

Bottom line: Real, well-tolerated benefit for cancer-related fatigue at the dose, form, and quality used in the Barton trial.

Type 2 diabetes / glycemic control

Disease adjunct
Good Evidence

A 2014 meta-analysis of 16 RCTs (n=770) of ginseng for glycemic control in T2DM or healthy adults found significant reduction in fasting blood glucose (−0.31 mmol/L, ~−5.6 mg/dL); modest HbA1c reduction was not statistically significant. The Mucalo 2013 American ginseng RCT in 64 T2DM patients found 3 g/day for 8 weeks improved fasting glucose, HbA1c, and arterial stiffness. Effect size is modestuseful as adjunct, not substitute for proven glucose-lowering therapy.

Effect size
Fasting glucose ~−6 mg/dL pooled; HbA1c reduction inconsistent across trials
Time to effect
4–12 weeks
Best fit
Adults with T2DM looking for modest adjunct to diet, exercise, and proven medications, under clinician oversight
Less likely
People with type 1 diabetes; people expecting ginseng to replace metformin / GLP-1 / insulin

Bottom line: Modest glycemic benefit. Adjunct, not substitute. Watch for additive hypoglycemia with prescribed medications.

Cognitive function / mental performance

Mechanism only
Limited Evidence

The 2010 Cochrane review of ginseng for cognitive function in healthy adults and dementia concluded modest cognitive subscale improvements have been reported but evidence is insufficient to recommend ginseng as a cognitive enhancer. Small trials (Reay, Kennedy, and Scholey lab studies) have shown acute and subchronic effects on attention and mental fatigue at 200400 mg/day standardized extract, but durable, clinically meaningful gains in healthy adults are not established.

Effect size
Small acute and subchronic improvements on selected cognitive subscales; clinical relevance uncertain
Time to effect
Acute (hours) for some attention tasks; weeks for fatigue endpoints
Best fit
Adults experimenting with low-risk cognitive adjuncts during demanding mental work
Less likely
Anyone expecting evidence-grade cognitive enhancement, or expecting clinically meaningful effects in dementia

Bottom line: Plausible mild cognitive adjunct; not a proven 'smart drug.'

Respiratory infection prevention (CVT-E002 / COLD-fX, American ginseng polysaccharide)

Supplement benefit
Limited Evidence

Predy 2005 (n=323 healthy adults) found 400 mg/day CVT-E002 (proprietary American ginseng polysaccharide extract, sold as COLD-fX in Canada) for 4 months reduced mean number of colds (0.68 vs 0.93) and total cold symptom days (5.6 vs 12.6). Several other adult trials (often industry-funded) corroborate. The Vohra 2008 pediatric trial in 75 children was negative. Effect is modest and largely tied to this one branded extractgeneric ginseng products may not deliver the same polysaccharide content.

Effect size
~25–30% reduction in cold incidence and total cold symptom days at 400 mg/day CVT-E002 over 4 months
Time to effect
4 months of consistent use during cold/flu season
Best fit
Older adults or institutional residents prone to recurrent colds; willing to use the specific branded product
Less likely
Children (pediatric trial negative); healthy adults expecting prevention of all respiratory infections

Bottom line: Modest cold-prevention benefit in adults using the specific CVT-E002 formulation. Don't extrapolate to generic ginseng extracts.

Evidence is mixed

Adult trials positive; pediatric trial negative. Effect specific to CVT-E002 polysaccharide formulation, not generic ginseng. Industry sponsorship of multiple adult trials.

General 'energy / adaptogen' use in healthy adults

Mechanism only
Weak Evidence

Outside the specific indications above (ED, cancer fatigue, glycemic control, cold prevention), the 'general energy / vitality / immune support / adaptogen' marketing for ginseng in healthy adults is weakly supported by clinical-endpoint RCT evidence. Cochrane 2010 and major reviews are not enthusiastic. Mechanism (ginsenoside modulation of HPA axis, glucocorticoid receptors, nitric oxide) is plausible but does not substitute for outcome data in healthy people.

Effect size
No reliable clinical-endpoint evidence in healthy adults for the marketed 'energy / immunity / adaptogen' claims
Time to effect
Not established for general use
Best fit
None at favorable evidence/risk profile
Less likely
Anyone expecting reproducible 'energy' or 'adaptogen' benefits without one of the specific evidence-based indications

Bottom line: If your goal is general 'energy' in a healthy adult, ginseng's evidence base doesn't reliably deliver — and the drug interactions still apply.

How it works

Gut microbiota convert ginsenosides to deglycosylated metabolites (compound K, Rh1) that are absorbed and act as adaptogens, modulating cortisol response, neurotransmitter systems, vascular tone, and immune function. Heat-processed (Korean red) ginseng has more Rg3 and Rh2, considered more bioactive for certain indications. Individual response varies based on gut microbiota.

How to take it

1. Typical dose
• Korean red ginseng (ED): 900–2,700 mg/day standardized extract (often 100–300 mg, 3× daily) • American ginseng (cancer fatigue): 1,000–2,000 mg/day pure ground root • American ginseng (T2DM): 1–3 g/day • CVT-E002 (cold prevention): 400 mg/day of the specific branded polysaccharide extract • Cycle: 8–12 weeks on, 2–4 weeks off, especially at higher doses
2. Higher studied dose
Up to 3 g/day American ginseng (Mucalo 2013) and up to 2.7 g/day Korean red ginseng have been used. Higher doses don't reliably add benefit and increase insomnia, hypertension, and headache.
3. Timing
Morning to early afternoon — stimulant-like effect can disrupt sleep when taken later. For ED: continuous daily dosing in trials, not on-demand.
4. With food
With food to reduce stomach upset, though absorption is similar fasted.
5. Split dosing
Split into 2–3 doses per day for higher total doses or if you experience jitteriness on a single morning dose.
6. How long to try
8–12 weeks to evaluate effect on ED, fatigue, or glycemic markers; 4 months for cold-prevention CVT-E002 protocol. Many practitioners recommend cycling (8 weeks on, 2 weeks off) at higher doses; clinical evidence for cycling is weak.

What to track

ED: IIEF score self-assessment at baseline and 12 weeks
Cancer fatigue: MFSI-SF or simple fatigue scale at baseline and 8 weeks
T2DM: fasting glucose, HbA1c at baseline and 12 weeks; watch for additive hypoglycemia with prescribed medications
BP and resting heart rate weekly — ginseng can raise both at higher doses
Sleep quality — afternoon/evening dosing commonly disrupts sleep
INR if on warfarin — case reports of decreased INR with ginseng

Bottom line: Match the form to the indication: Korean red for ED, American (pure root or CVT-E002 polysaccharide) for cancer fatigue / glycemic control / cold prevention. Watch BP, sleep, and drug interactions.

5 commercial forms

Compare the main delivery options and what they’re best suited for.

Korean red ginseng (Panax ginseng, steamed)

ED evidence

Asian/Korean ginseng (Panax ginseng) that has been steamed and driedconverts some ginsenosides to red ginseng-specific forms (Rg3, Rh2). The form used in most ED meta-analysis trials. KGC / Cheong Kwan Jang is the dominant standardized brand. Higher ginsenoside Rg1 content.

Standardized extracts ~4–7% total ginsenosides.

Asian ginseng (Panax ginseng, white/dried)

Classic form

The unsteamed form of Panax ginsengsun-dried after harvesting. Different ginsenoside profile from red ginseng (less Rg3, Rh2). Used in many cognitive function and general health trials.

Similar ginsenoside totals; different specific profile from red.

American ginseng (Panax quinquefolius)

Cancer fatigue / T2DM

Distinct species native to North America (especially Wisconsin and Ontario). Ginsenoside profile more Rb1, less Rg1traditionally considered 'cooler' / less stimulating than Korean. The Barton 2013 cancer-fatigue and Mucalo 2013 diabetes trials used this species. Pure ground root preferred for trial replication.

Pure ground root in the Barton trial; standardized extracts elsewhere.

CVT-E002 / COLD-fX (American ginseng polysaccharide)

Cold-prevention RCT product

Proprietary polysaccharide-enriched extract of American ginseng (Afexa Life Sciences, now Valeant). The product in the Predy 2005 adult RCT for cold prevention. Not the same as standard American ginseng extract; richer in polysaccharide bioactives.

Polysaccharide fraction (not ginsenoside) believed to drive cold-prevention effect.

'Siberian ginseng' (Eleutherococcus senticosus) — NOT a Panax

Different plant entirely

Often shelved next to ginseng but botanically and pharmacologically distinct (no ginsenosides; contains eleutherosides). Don't substitute it for Panax ginseng in the evidence base.

Different active class; different evidence base.

Safety

Know the common side effects, key cautions, and who should avoid it.

Common side effects

insomniaheadacheanxiety / restlessnesshypertension at higher dosesGI upsetdiarrheabreast tendernessvaginal bleeding (rare; high-dose)

Serious risks

Who should avoid it

Pregnancy & breastfeeding

Avoid in pregnancy and breastfeeding. Animal data show some ginsenosides cross the placenta; one (Rb1) was teratogenic in rat studies at very high doses. Human safety data in pregnancy are insufficient. Discuss with obstetrician if already taking; tapering is generally appropriate.

Bottom line: Real drug interactions and BP/sleep side effects — not as benign as 'food' marketing implies. Match form to indication, mind the interactions, monitor BP and sleep.

Interactions

MAOIs (phenelzine, tranylcypromine, selegiline, linezolid)Major

Risk of hypertensive crisis and mania. Case reports document the combination. Absolute contraindication.

warfarinMajor

Case reports of reduced INR with concomitant ginseng. Avoid combination; if unavoidable, monitor INR closely with frequent rechecks.

insulin and sulfonylureas (glipizide, glyburide, glimepiride)Moderate

Additive hypoglycemia — monitor glucose closely when starting or stopping ginseng in anyone on insulin or sulfonylureas.

stimulants (caffeine, ephedrine, amphetamines, decongestants)Moderate

Additive stimulant effect — increases insomnia, anxiety, BP, HR. Avoid stacking.

antihypertensives (ACE inhibitors, ARBs, calcium channel blockers, beta-blockers)Moderate

Ginseng can raise BP, opposing antihypertensive action; effect varies. Monitor BP when adding or stopping.

CYP3A4 substrates (statins, calcium channel blockers, cyclosporine, sildenafil)Moderate

Some ginsenosides inhibit or induce CYP3A4 in vitro; clinical relevance varies by product and dose. Check the specific drug's grapefruit-juice / CYP3A4 list and discuss with pharmacist.

antiplatelets and anticoagulants (aspirin, clopidogrel, DOACs)Moderate

Some ginsenosides have antiplatelet activity in vitro; theoretical additive bleeding risk. Discuss with cardiologist before combining.

Food sources

Panax ginseng root (raw or dried)

Amount
Culinary use mostly in Korean and Chinese cooking; ginseng chicken soup (samgyetang)
%DV

Panax quinquefolius (American ginseng) root

Amount
Sometimes consumed in soups or teas; commercially mostly extracted for supplements
%DV

Ginseng tea (steeped sliced root)

Amount
1 cup brewed from 2–5 g root — modest ginsenoside delivery
%DV

Choosing a product

What to look for on the label — and what to be skeptical of.

Look for

Species and form clearly stated: Panax ginseng (Asian / Korean red) vs Panax quinquefolius (American) — different evidence bases for different indications
Standardized to total ginsenoside content (typically 4–7% for Korean red ginseng standardized extracts)
Authentic Korean red ginseng (KGC / Cheong Kwan Jang) for ED evidence base; Wisconsin-grown American ginseng for cancer-fatigue evidence base
Third-party tested for pesticide residues and heavy metals — Asian ginseng has had a few notable contamination reports historically
Single-ingredient product so you can match dose to the relevant trial

Be skeptical of

'Universal adaptogen' marketing — works for ED or cancer fatigue or glycemic control with specific products; doesn't 'adapt' to whatever you need
'Boosts immune system' for healthy adults — outside the CVT-E002 cold-prevention trial, evidence is weak
'Increases testosterone' — small unreliable signals only; weak human evidence
Mega-dose products (>3 g/day) for 'peak energy' — more side effects without added benefit
Generic 'ginseng' products without species or standardization — could be Panax ginseng, Panax quinquefolius, or 'Siberian ginseng' (Eleutherococcus, not a Panax) with different pharmacology

Frequently asked questions

What's a ginsenoside?

A class of saponins from ginseng that, after gut metabolism, account for the herb's effects.

Should I take ginseng daily?

Most users cycle (e.g., 8 weeks on, 2 off) to limit tolerance and side effects.

References by claim

Erectile dysfunction (Korean red ginseng)

Memorial Sloan Kettering — About HerbsAsian Ginseng (Panax ginseng) monograph (2024) link

Jang et al., 2008British Journal of Clinical Pharmacology (2008) link

Cancer-related fatigue (American ginseng)

Memorial Sloan Kettering — About HerbsAmerican Ginseng (Panax quinquefolius) monograph (2024) link

Barton et al., 2013Journal of the National Cancer Institute (2013) link

Type 2 diabetes / glycemic control

Shishtar et al., 2014PLOS ONE (2014) link

Mucalo et al., 2013Journal of Ethnopharmacology (2013) link

Cognitive function / mental performance

Geng et al. (Cochrane), 2010Cochrane Database of Systematic Reviews (2010) link

Respiratory infection prevention (CVT-E002 / COLD-fX, American ginseng polysaccharide)

Predy et al., 2005CMAJ (2005) link

Vohra et al., 2008PLOS ONE / Pediatrics (2008) link

Track Ginsenosides with Pilora

Set up dose reminders, check interactions, and join the community in the Pilora iPhone app.

Coming to App Store
Evidence-based·Last reviewed May 31, 2026·Evidence current as of May 31, 2026·How we grade evidence

Disclaimer: These statements have not been evaluated by the FDA. This page is educational, not a substitute for personalized medical advice. Evidence grades are AI-assisted assessments — talk to your doctor before starting any new supplement, especially if you’re pregnant, breastfeeding, on medications, or managing a chronic condition.